MedTrace Logo

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

NCT06457438 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-06-13

No results posted yet for this study

Summary

In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.

Conditions

  • Hepatitis E

Interventions

DIAGNOSTIC_TEST

Elecsys Anti-HEV IgG, IgM

Diagnostic test used to determine antibodies in blood and serum.

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Hana Slepčanová, Mgr. · University Hospital Ostrava

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06457438 on ClinicalTrials.gov